Bacterial inclusion bodies: An emerging platform for drug delivery and cell therapy

Nanomedicine

Volumn 7, Issue 9, 2012, Pages 1277-1279

  Villaverde, Antonio ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

amyloids; drug delivery; inclusion bodies; nanostructured materials; therapy

Indexed keywords

BACTERIUM; CELL INCLUSION; CELL THERAPY; DRUG DELIVERY SYSTEM; EDITORIAL; NONHUMAN; PRIORITY JOURNAL;

AMYLOID; ANIMALS; BACTERIA; DRUG CARRIERS; HUMANS; INCLUSION BODIES; NANOSTRUCTURES; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS; TISSUE THERAPY;

EID: 84866700940     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.100     Document Type: Editorial

References (20)

1. Gasser B, Saloheimo M, Rinas U et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb. Cell Fact. 7, 11 (2008).
2. Vazquez E, Corchero JL, Villaverde A. Post-production protein stability: trouble beyond the cell factory. Microb. Cell Fact. 10(1), 60 (2011).
3. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 22(11), 1399-1408 (2004).
4. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Recombinant protein solubility-does more mean better? Nat. Biotechnol. 25(7), 718-720 (2007).
5. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb. Cell Fact. 7(1), 34 (2008).
6. Upadhyay AK, Murmu A, Singh A, Panda AK. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli. PLoS ONE 7(3), e33951 (2012).
7. Garcia-Fruitos E, Vazquez E, Díez-Gil C et al. Bacterial inclusion bodies: making gold from waste. Trends Biotechnol. 30(2), 65-70 (2012).
8. Garcia-Fruitos E, Sabate R, de Groot NS, Villaverde A, Ventura S. Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J. 278(14), 2419-2427 (2011).
9. Ventura S, Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24(4), 179-185 (2006).
10. Morell M, Bravo R, Espargaro A et al. Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim. Biophys. Acta 1783(10), 1815-1825 (2008).
11. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S. Amyloid-like properties of bacterial inclusion bodies. J. Mol. Biol. 347(5), 1025-1037 (2005).
12. Speed MA, Wang DI, King J. Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat. Biotechnol. 14(10), 1283-1287 (1996).
13. Villaverde A. Nanotechnology, bionanotechnology and microbial cell factories. Microb. Cell Fact. 9, 53 (2010).
14. Cherny I, Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. Engl. 47(22), 4062-4069 (2008).
15. Seras-Franzoso J, Díez-Gil C, Vazquez E et al. Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering. Nanomedicine (Lond.) 7(1), 79-93 (2012).
16. Vazquez E, Corchero JL, Burgueno JF et al. Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv. Mater. 24(13), 1742-1747 (2012).
17. Liovic M, Ozir M, Bedina ZA, Peternel S, Komel R, Zupancic T. Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells. Microb. Cell Fact. 11(1), 67 (2012).
18. Iconomidou VA, Hamodrakas SJ. Natural protective amyloids. Curr. Protein Pept. Sci. 9(3), 291-309 (2008).
19. Maji SK, Perrin MH, Sawaya MR et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325(5938), 328-332 (2009).
20. Maji SK, Schubert D, Rivier C, Lee S, Rivier JE, Riek R. Amyloid as a depot for the formulation of long-acting drugs. PLoS Biol. 6(2), e17 (2008).